Antiarrhythmic Treatment in Atrial Fibrillation

Seema Ledan, PharmD


US Pharmacist. 2020;45(2):24-27. 

In This Article


AF is the most common arrhythmia, with prevalence increasing with age; multiple agents are available for its management. Although data are unavailable to support favorable morbidity and mortality outcomes, restoration of sinus rhythm may prevent the progression of AF and improve the quality of life in early intervention. However, due to the nature of the side effects or monitoring requirements of antiarrhythmics, therapy selection should be based first upon safety and then upon efficacy.